DNA reactivity as a mode of action and its relevance to cancer risk assessment

Toxicologic Pathology

Volumn 41, Issue 2, 2013, Pages 322-325

  Preston, R Julian ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

cancer; DNA reactivity; key events; mode of action; mutation

Indexed keywords

BIOLOGICAL MARKER; DNA;

ANGIOGENESIS; ARTICLE; CANCER RISK; CELL ENERGY; CELL MUTANT; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMOSOME MUTATION; DNA ADDUCT; DNA DAMAGE; DNA METHYLATION; DNA SEQUENCE; GENE MUTATION; GENOME; GENOMIC INSTABILITY; HUMAN; METASTASIS; MUTAGENICITY; NEOPLASM; PRIORITY JOURNAL; RISK ASSESSMENT; TARGET CELL;

CARCINOGENS; DNA; DNA DAMAGE; HUMANS; MUTAGENICITY TESTS; NEOPLASMS; RISK ASSESSMENT;

EID: 84875757482     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623312464437     Document Type: Article

References (19)

1. Besaratinia A., Kim S. I., Hainaut P., Pfeifer G. P.. In vitro recapitulation of TP 53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin exposure. Gastroenterology. 2009 ; 137: 1127-37
2. Boobis A. R., Daston G. P., Preston R. J., Olin S. S.. Application of key events analysis to chemical carcinogens and noncarcinogens. Crit Rev Food Sci Nutr. 2009 ; 49: 690-707
3. Doak S. H., Jenkins G. J., Johnson G. E., Quick E., Parry E. M., Parry J. M.. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res. 2007 ; 67: 3904-11
4. Greenman C., Stephens P., Smith R., Dalgliesh G. L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D. P., Louis D. N., Goldstraw P., Nicholson A. G., Brasseur F., Loojenga L., Weber B. L., Chiew Y. E., DeFazio A., Greaves M.F., Green A. R., Campbell P., Birney E., Easton D. F., Chenevix-Trench G., Tan M. H., Khoo S. K., The B. T., Yuen S. T., Leung S. Y., Wooster R., Futreal P. A., Stratton M. R.. Patterns of somatic mutation in human cancer genomes. Nature. 2007) ; 446: 153-58
5. Hanahan D., Weinberg R. A.. The hallmarks of cancer. Cell. 2000 ; 100: 57-70
6. Hanahan D., Weinberg R. A.. Hallmarks of cancer: The next generation. Cell. 2011 ; 144: 646-74
7. Kalari S., Pfeifer G. P.. Identification of driver and passenger DNA methylation cancer by epigenomic analysis. Adv Genet. 2010 ; 70: 277-308
8. Minko I. G., Kozekov I. D., Kozecova A., Harris T. M., Rizzo C. J., Lloyd R. S.. Mutagenic potential of DNA-peptide crosslinks mediated by acrolein-derived DNA adducts. Mutat Res. 2008 ; 637: 161-72
9. Risk Assessment in the Federal Government: Managing the Process. National Academy Press: Washington, DC ; 1983 :
10. Science and Judgment in Risk Assessment. National Academy Press: Washington, DC ; 1994 :
11. Ottolenghi A., Ballarini F., Merzagora M.. Modelling radiation-induced biological lesions: From initial energy depositions to chromosome aberrations. Radiat Environ Biophys. 1999 ; 38: 1-13
12. Pfeifer G. P.. Mutational spectra of human cancer. Hum Genet. 2009 ; 125: 493-506
13. Pleasance E. D., Cheetham R. K., Stephens P. J., McBride D. J., Humphray S. J., Greenman C. D., Varela I., Lin M.-L., Ordonez G. R., Bignell G. R., Ye K., Alipaz J., Bauer M. J., Beare D., Butler A., Carter R. J., Chen L., Cox A. J., Edkins S., Kokko-Gonzales P. I., Gormley N. A., Grocock R. J., Haudenschild C. D., Hims M. M., James T., Jia M., Kingsbury Z., Leroy C., Marshall J., Menzies A., Mudie L. J., Ning Z., Royce T., Schulz-Trieglaff O. B., Spiridou A., Stebbings L. A., SzajKowski L., Teague J., Williamson D., Chin L., Ross M. T., Campbell P. J., Bentley D. R., Futreal P. A., Stratton M. R.. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature. 2010 ; 463: 191-97
14. Preston R. J., Ross J. A. 2010 ). Chapter 1.16, Mechanisms: DNA-reactive Agents. In Comprehensive Toxicology, 2nd Ed. (McQueenC. A., ed), pp. 349-360Elsevier, Oxford, UK McQueen C. A., ed. Elsevier Oxford, UK ; 2010: 349-360.
15. Preston R. J., Williams G. M.. DNA-reactive carcinogens: Mode of action and human cancer hazard. Crit Rev Toxicol. 2005 ; 35: 673-83
16. Steel G.G.. From targets to genes: A brief history of radiosensitivity. Phys Med Biol. 1996 ; 41: 205-22
17. Stoler D. L., Chen N., Basik M., Kahlenberg M. S., Rodriguez-Biga M. A., Petrell N. J., Anderson G. R.. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci USA. 1999 ; 96: 15121-26
18. Swenberg J. A., Fryar-Tita E., Jeong Y. C., Boysen G., Starr T., Walker V. E., Albertini R. J.. Biomarkers in toxicology and risk assessment; informing critical dose-response relationships. Chem Res Toxicol. 2008 ; 21: 253-65
19. US EPA (U.S. Environmental Protection Agency) (2005). Guidelines for Carcinogen Risk Assessment, Risk Assessment Forum, US Environmental Protection Agency, Washington, DC. http://www.epa.gov/raf/publications/pdfs/CANCER- GUIDELINES-FINAL-3-25-05.PDF. Accessed October 10, 2012.